Interesting to note that MTY is one of only 4 “biotechs” that has consistently traded above its IPO price since listing;
AND
With the Nature Vet acquisition will be one of only 3 “biotechs” in Australia with revenue of over $10 million (of all of those with market cap under $100 million).
DYOR
Cheers.
Interesting to note that MTY is one of only 4 “biotechs” that...
Add to My Watchlist
What is My Watchlist?